Portal de Periódicos da CAPES

Levodopa use in Denmark: high levels in Greenland and the Faroe Islands

2009; Wiley; Volume: 91; Issue: 2 Linguagem: Inglês

10.1111/j.1600-0404.1995.tb00413.x

1600-0404

Jesús de Pedro‐Cuesta, Lene Wermuth, Víctor Abraira, Leszek Stawiarz,

Neurotransmitter Receptor Influence on Behavior

Acta Neurologica ScandinavicaVolume 91, Issue 2 p. 89-97 Levodopa use in Denmark: high levels in Greenland and the Faroe Islands J. de Pedro-Cuesta, Corresponding Author J. de Pedro-Cuesta Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain Unit for Neuroepidemiology and Health Services Research, Division of Neurology, Huddinge Hospital, Karolinska Institute, SwedenJesús de Pedro-Cuesta, Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health, C/Sinesio Delgado 6, 28029 Madrid, SpainSearch for more papers by this authorL. Wermuth, L. Wermuth Department of Neurology, Odense University Hospital, Odense, DenmarkSearch for more papers by this authorV. Abraira, V. Abraira Methodology Unit, Subdirectorate of Research, Spanish Ministry of Health and Research Unit, "Ramon y Cajal" Hospital, Madrid, SpainSearch for more papers by this authorL. Stawiarz, L. Stawiarz Unit for Neuroepidemiology and Health Services Research, Division of Neurology, Huddinge Hospital, Karolinska Institute, SwedenSearch for more papers by this author J. de Pedro-Cuesta, Corresponding Author J. de Pedro-Cuesta Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain Unit for Neuroepidemiology and Health Services Research, Division of Neurology, Huddinge Hospital, Karolinska Institute, SwedenJesús de Pedro-Cuesta, Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health, C/Sinesio Delgado 6, 28029 Madrid, SpainSearch for more papers by this authorL. Wermuth, L. Wermuth Department of Neurology, Odense University Hospital, Odense, DenmarkSearch for more papers by this authorV. Abraira, V. Abraira Methodology Unit, Subdirectorate of Research, Spanish Ministry of Health and Research Unit, "Ramon y Cajal" Hospital, Madrid, SpainSearch for more papers by this authorL. Stawiarz, L. Stawiarz Unit for Neuroepidemiology and Health Services Research, Division of Neurology, Huddinge Hospital, Karolinska Institute, SwedenSearch for more papers by this author First published: February 1995 https://doi.org/10.1111/j.1600-0404.1995.tb00413.xCitations: 5AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Abstract Levodopa (LD) sales from wholesalers to pharmacies during the periods, 1977–1989 in Denmark, 1981–1989 in Greenland, and April 1988–May 1989 in Danish counties and the Faroe Islands, were evaluated using a reported method and a procedure expressly developed for assessment of random variation comparative levodopa use (LDU) measurements. The reference population for comparison of LDU was the Swedish from 1984. LDU diffusion had stabilized by 1989 in Denmark, but considerable annual increments of LD sales were still seen in Greenland in 1989. Crude LDU in Denmark and most Danish counties amounted to a level similar to that of Sweden. Adjustments for age and infant mortality rates, taken as an indicator of socioeconomic development, disclosed statistically significant twofold levels of LDU in the Faroe Islands and Greenland, and lowest LDU in urban regions. The social or biological factors underlying such differences in drug use remain unknown. Citing Literature Volume91, Issue2February 1995Pages 89-97 RelatedInformation